NextCure NXTC
NASDAQ NXTC
$6.40 +0.17 (+2.73%)
At close: Nov 13, 2026 · 4:00 PM EST

NextCure (NXTC) Sale and Maturity of Investments (2020 - 2026)

Updated

NextCure's Sale and Maturity of Investments - Total was $4.84 million in Q3 2026, down 44.4% from $8.7 million a year earlier and down 50.6% from the prior quarter.

Analysis

NextCure (NXTC) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, NextCure's Sale and Maturity of Investments - Total was $21.93 million through Sep 30, 2026, down 64.4% year-over-year; for FY2025, it came in at $52.26 million, down 49.9% from FY2024.

  • Sale and Maturity of Investments - Total shows a five-year compound annual growth rate of -22.6% (FY2020 to FY2025).
  • In earlier years, Sale and Maturity of Investments - Total was $104.23 million in FY2024 (-8.2%), $113.6 million in FY2023 (+8.5%), $104.74 million in FY2022 (-46.4%) and $195.44 million in FY2021 (+4.1%).
  • Quarterly Sale and Maturity of Investments - Total has moved between $1.3 million (Q1 2026) and $49.77 million (Q1 2023) over five years.
  • Compared with a year earlier, Sale and Maturity of Investments - Total has declined for eight straight quarters, with an average decline of 48.7% over the last eight quarters.
  • The best year-over-year quarter for Sale and Maturity of Investments - Total over five years was Q1 2023 (growth of 255.3%); the worst was Q1 2026 (a decline of 93.8%).
  • Per Business Quant data, NXTC's Sale and Maturity of Investments - Total in the three quarters before Q3 2026 was $9.79 million (Q2 2026), $1.3 million (Q1 2026) and $6 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 308.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - 88.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.53 Bn
10 NextCure 29.30 Mn -71.08 Mn - 4.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.84 Mn
Jun 30, 2026 9.79 Mn
Mar 31, 2026 1.30 Mn
Dec 31, 2025 6.00 Mn
Sep 30, 2025 8.70 Mn
Jun 30, 2025 16.50 Mn
Mar 31, 2025 21.06 Mn
Dec 31, 2024 15.26 Mn
Sep 30, 2024 25.00 Mn
Jun 30, 2024 34.91 Mn
Mar 31, 2024 29.06 Mn
Dec 31, 2023 15.99 Mn
Sep 30, 2023 10.56 Mn
Jun 30, 2023 37.28 Mn
Mar 31, 2023 49.77 Mn
Dec 31, 2022 26.71 Mn
Sep 30, 2022 23.80 Mn
Jun 30, 2022 40.22 Mn
Mar 31, 2022 14.01 Mn
Dec 31, 2021 24.40 Mn
API Access

NextCure Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=NXTC&period=max&api_key=YOUR_API_KEY